More than a marker: potential pathogenic functions of MAP2.

Front Mol Neurosci · 2022 · PMC9525131 · PMID 36187353

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

( 1997 ) showed a trend toward decreased immunoreactivity by Ab305—a MAP2 antibody which recognizes pT1616/pT1619 in the proline-rich domain—in hippocampus of individuals with schizophrenia.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.